![](/img/cover-not-exists.png)
Can SGLT-2 inhibitors resolve the heart failure burden of Diabetes mellitus- is it Empaglifozin or the class?
Tschöpe, DiethelmLanguage:
english
Journal:
Journal of Diabetes and its Complications
DOI:
10.1016/j.jdiacomp.2017.04.020
Date:
April, 2017
File:
PDF, 348 KB
english, 2017